sales@gblpharma.com
25-27 Juni 2026 · Pekanbaru
Global Pharma Participates in HISFARSI 2026 Pekanbaru
Global Pharma participated in the 2026 Annual Scientific Meeting and National Working Conference of the Indonesian Hospital Pharmacy Association, known as PIT & Mukernas HISFARSI 2026. The national event was held in Pekanbaru, Riau, from June 25 to 27, 2026.
Carrying the theme “Building a Safer Healthcare System: The Pharmacist’s Role in Digital and Performance Innovation,” HISFARSI 2026 brought together hospital pharmacists from across Indonesia, regulators, professional organizations, academics, industry representatives, and healthcare institutions.
The event provided an important forum for discussing patient safety, digital transformation, professional competency, and performance innovation within hospital pharmacy services.
Global Pharma’s participation in HISFARSI 2026 formed part of the company’s ongoing commitment to building stronger relationships and collaboration with pharmaceutical professionals, particularly hospital pharmacists.
Throughout the event, Global Pharma had the opportunity to engage directly with participants and gain valuable insights into the evolving needs of hospitals and healthcare institutions.
Discussions covered several important areas, including challenges in managing medical supplies, the changing operational requirements of hospitals, and the importance of ensuring access to quality medical equipment, hospital instruments, and laboratory supplies.
These interactions provided valuable input for Global Pharma as the company continues to develop services that are increasingly responsive to the needs of healthcare institutions across Indonesia.
PIT & Mukernas HISFARSI 2026 highlighted patient safety, digitalization, professional development, and performance innovation as essential elements in the transformation of hospital pharmacy services.
The event featured a series of scientific seminars, workshops, research presentations, professional competitions, and discussions covering clinical pharmacy and pharmaceutical management.
These topics reflected the growing need for healthcare services that are not only effective and efficient but also safe, measurable, and focused on improving patient outcomes.
This commitment aligns with Global Pharma’s vision of supporting improvements in healthcare quality by providing medical equipment, hospital instruments, and laboratory supplies that respond to the practical needs of healthcare professionals and institutions.
For Global Pharma, supplying healthcare products involves more than distribution. It also means building trust, maintaining service quality, and helping healthcare professionals perform their responsibilities more effectively and safely.
HISFARSI 2026 served as a strategic platform for exchanging knowledge, experience, and best practices in hospital pharmacy services.
The forum was attended by more than one thousand hospital pharmacists from various provinces across Indonesia. It also provided an important opportunity to strengthen the role of pharmacists in ensuring that medicines are used safely, effectively, responsibly, and with a patient-centered approach.
The range of topics discussed during the event demonstrated that the future of healthcare will require closer collaboration between pharmacists, medical professionals, government institutions, hospitals, academics, professional organizations, and industry partners.
By bringing these stakeholders together, HISFARSI creates opportunities to develop shared perspectives and explore solutions to the challenges faced by modern hospital pharmacy services.
Healthcare institutions continue to face changing demands related to patient safety, digital systems, supply management, operational efficiency, and service quality.
Through its participation in HISFARSI 2026, Global Pharma gained a deeper understanding of these developments and the role that reliable healthcare products and responsive industry partnerships can play in supporting hospital operations.
The company remains committed to listening to healthcare professionals and understanding the realities they face in their daily work. These insights are important in ensuring that the products and services provided remain relevant to the needs of hospitals, laboratories, and other healthcare facilities.
Global Pharma’s presence at HISFARSI 2026 reflects its continued commitment to contributing to the development of Indonesia’s healthcare sector through collaboration, quality products, professional engagement, and responsive service.
The company hopes its participation will create further opportunities for communication and cooperation with hospital pharmacists, healthcare institutions, and other stakeholders.
Through long-term partnerships and an ongoing understanding of industry needs, Global Pharma aims to support healthcare professionals in delivering safer, more effective, and higher-quality services to patients throughout Indonesia.
Global Pharma Assistant
Website information is general. Please contact our team for medical advice.




